Cargando…
Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19
BACKGROUND: The adverse effects of proton pump inhibitors (PPIs) on pneumonia have been well reported. However, the relationship between the use of PPIs and the adverse outcomes of coronavirus disease 2019 (COVID-19) is currently inconclusive. In this study, we aimed to explore the relationship betw...
Autores principales: | Wu, Shengyong, Jin, Zhichao, Peng, Chi, Li, Dongdong, Cheng, Yi, Zhu, Ronghui, He, Jia, Wu, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849264/ https://www.ncbi.nlm.nih.gov/pubmed/35198150 http://dx.doi.org/10.7189/jogh.12.05005 |
Ejemplares similares
-
Prevalence of oropharyngeal dysphagia and risk of mortality among hospitalized COVID-19 patients: A meta-analysis
por: Lee, Chi-Li, et al.
Publicado: (2022) -
In-hospital mortality of COVID-19 in Iranian children and youth: A multi-centre retrospective cohort study
por: Fattahi, Pedram, et al.
Publicado: (2022) -
Arbidol is associated with increased in-hospital mortality among 109 patients with severe COVID-19: A multicenter, retrospective study
por: Zhou, Xianlong, et al.
Publicado: (2021) -
COVID-19 mortality among pregnant women in Mexico: A retrospective cohort study
por: Ríos-Silva, Mónica, et al.
Publicado: (2020) -
Risk of COVID-19 hospitalizations among school-aged children in Scotland: A national incident cohort study
por: Shi, Ting, et al.
Publicado: (2022)